Leritrelvir
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Leritrelvir (RAY1216) is an antiviral drug which acts as a 3C-like protease inhibitor. It was developed and approved in China for treatment of COVID-19.
Source: Wikipedia "Leritrelvir" · CC BY-SA 4.0
Share this article: X · Bluesky